Mylan's EpiPen Price Increases Highlight Its Grip on Market - Wall Street Journal
| Wall Street Journal | Mylan's EpiPen Price Increases Highlight Its Grip on Market Wall Street Journal The ability of Mylan MYL -0.70 % NV to raise EpiPen's list price by nearly 550% over the past eight years underscores the pricing power drug companies enjoy for iconic brands facing little competition. EpiPen dominates the more than $1 billion market ... What Mylan's EpiPen Cost Scandal Says About the Drug Price Problem Discounts Aren't Enough to Halt Outrage At High EpiPen Prices Pricing of EpiPens merits scrutiny, committee hearings |